Navigation Links
United Therapeutics Announces Collaboration With Ascendis Pharma To Develop Self-Injectable Treprostinil For Pulmonary Arterial Hypertension
Date:9/20/2012

SILVER SPRING, Md., Sept. 20, 2012 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has signed an exclusive agreement with Ascendis Pharma A/S to apply Ascendis Pharma's proprietary TransCon technology platform to United Therapeutics' treprostinil molecule, the active ingredient in Remodulin® (treprostinil) injection.  United Therapeutics believes that the TransCon technology platform may enable a controlled, long-acting release of a novel, carrier-linked product, significantly enhancing the delivery profile of treprostinil by establishing a self-injectable alternative for patients who currently use the drug via a continuous infusion pump for the treatment of pulmonary arterial hypertension (PAH).

"We are thrilled to enter into this license agreement with Ascendis Pharma," said Martine Rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive Officer.  "The potential to bring another novel therapeutic option to PAH patients represents an exciting new opportunity for Remodulin delivery as we constantly re-charge our mission to better the lives of patients suffering from PAH."

"Pre-clinical studies in multiple animal models with a lead compound of TransCon-linked treprostinil have already produced encouraging results, demonstrating a sustained release profile supportive of once-daily injection.  The application of TransCon technology to treprostinil may also minimize injection site pain and reactions that frequently occur with continuously infused subcutaneous Remodulin," commented Roger Jeffs, Ph.D., United Therapeutics' President and Chief Operating Officer.  "We are very excited to be working with Ascendis Pharma to further develop and advance this promising product into the clinic."

Under the terms of the agreement, United Therapeutics will also have exclusive rights to develop prostacycl
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. United Seating & Mobility Completes Acquisition of Glass Seating & Mobility
2. Philips and Corindus announce distribution agreement to sell Corindus robotic-assisted interventional cardiology system in the United States
3. Pharmacists United for Truth and Transparency Marks One Year Anniversary of Fighting Abuses by Pharmacy Benefits Managers
4. United Spinal Appointed to U.S. Access Board: Developing Accessible Standards for Medical Diagnostic Equipment
5. Alternate Distribution Channels Claim Opportunities for OTC Drug Sales in the United States, Finds Kline
6. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
7. United Seating & Mobility Completes Acquisition of Active American Mobilitys Rehab Division
8. United Seating & Mobility Completes Acquisition of Active American Mobility
9. Celladon Corporation Receives Patent from United States Patent and Trademark Office
10. 2012 United States Medical Devices Outlook
11. United States Market for Psoriatic Arthritis Pharmacotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 2015 The Physician-Patient Alliance for Health ... 28, 2015, "Surviving Your Hospital Stay: Physician-Patient Alliance ... Safety." A sentence was omitted from ... "PPAHS is a member of the National Coalition ... information on the National Coalition to Promote Continuous Monitoring ...
(Date:7/31/2015)... , July 31, 2015  Boston Children,s ... benefiting from 3D printing of their anatomy before ... life-threatening cerebrovascular malformations (abnormalities in the brain,s blood ... Reporting online today in the Journal of ... of 3D printing and synthetic resins to create ...
(Date:7/31/2015)... According to a new market research ... Heat, Ethylene Oxide, Filtration, E-beam, Gamma), Services (Onsite & Offsite), ... Global Forecast to 2020", published by MarketsandMarkets, The Sterilization Equipment ... 2020, at a CAGR of 7.6%.from 2015 to 2020. ... T ables and 37 F ...
Breaking Medicine Technology:3D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4
... Effectiveness of Autologous Therapy, DUSSELDORF, Germany, ... two-year,representative study of knee osteoarthritis, published in ... safety and effectiveness of Orthokine therapy, in ... blood are,injected into the arthritic joint., ...
... New Therapeutic Platform in Patients with Cystoid Macular ... ... Aug. 5 Icon Bioscience, Inc., (IBI),a privately held ophthalmic pharmaceutical ... clinical trial to assess the,safety and efficacy of its lead product, ...
Cached Medicine Technology:Orthokine Treatment is Effective for Knee Arthritis, Even After Two Years 2Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate 2
(Date:7/31/2015)... ... 2015 , ... The 2015 ALS Ice Bucket Challenge will officially get underway ... Sox honor Ice Bucket co-founders Pat Quinn and Pete Frates, the ALS community and ... efforts among the ALS organizations to find treatments and cures for the disease. ...
(Date:7/31/2015)... ... July 31, 2015 , ... BioViva USA, Inc. (“BioViva”), a to-clinic gene therapy ... , BioViva announces it has begun a fundraiser through Maximum Life Foundation (“MaxLife”) ... find a cure. MaxLife will grant 100% of the money raised to BioViva to ...
(Date:7/31/2015)... ... July 31, 2015 , ... Like nearly every other form of surgery, it ... made more effective and less intrusive and painful. Leading these advances in the ... Dr. Loria currently stands as the only doctor in the United States who is ...
(Date:7/31/2015)... ... 2015 , ... Recently, ZKB filed another federal lawsuit in ... No. 3:15-cv-00397) involving the Implanon® contraceptive implant . , As described in ... implants, inability to locate the implants, unsuccessful and invasive attempts at implant removal, ...
(Date:7/31/2015)... ... July 31, 2015 , ... Successful ... DC, http://www.fdanews.com/importexportprogram , Having FDA-regulated products held at ports costs time, ... of risking containment — or even destruction — of products, an FDA insider ...
Breaking Medicine News(10 mins):Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 4Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 2Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 4
... of Pennsylvania School of Medicine and other study sites ... non-invasive technique that excites neurons in the brain via ... safe and effective, non-drug treatment with minimal side effects ... treatment options without benefit. , This study ...
... generates green pods while a variant of that gene ... helped Gregor Mendel, the 19th century Austrian priest and ... are focused on the strange ability of some genes ... ways. , In order to better understand this phenomenon ...
... researchers have identified structural damage to the lungs caused ... the study, conducted by researchers at the University of ... Hospital of Philadelphia in Pennsylvania, were presented today at ... America (RSNA). , Its long been hypothesized that prolonged ...
... of Australias leading medical,research institutes, unveiled a powerful ... cutting edge in medical technology and microscopy, the ... scientists at the Centenary Institute,unprecedented access to the ... and molecular,level., The Centenary Institute is equally excited ...
... CARLSBAD, Calif., Nov. 26 Visage Imaging, a,wholly ... MRCY ),announced an agreement with Siemens Medical ... solutions to hospitals and imaging,centers worldwide., Siemens ... into its SIENET Magic product line. This unique ...
... Ohio, Nov. 26 Understand how improving ... That,s the message behind,the new book "REM ... by Timothy J. Walter, M.D., a sleep ... (Lotus Magnus, August,2007, ISBN-13: 978-1604022377, $19.95) integrates ...
Cached Medicine News:Health News:Penn research shows transcranial magnetic stimulation effective in treating major depression 2Health News:Flip-flopping gene expression can be advantageous 2Health News:Novel MRI technique shows secondhand smoke damages lungs 2Health News:World class technology and talent battle cancer at the Centenary Institute 2Health News:Visage Imaging Expands Availability of Its Advanced Visualization Offering 2Health News:Visage Imaging Expands Availability of Its Advanced Visualization Offering 3Health News:Understand How Sleep Impacts Learning and Memory 2
The Leica M500 OH3 is an advanced surgical microscope used by neurosurgeons. It is a smart system combining the best optical performance available on the market with an innovative and unique stand....
Surgical Loupes...
... MAGNETOM Allegra is the ultimate brain ... been optimized for best image quality ... all in a highly compact design. ... diagnosing stroke, epilepsy, tumor and multiple ...
Signa Profile is built on the Signa foundation to deliver speed & image quality....
Medicine Products: